门诊抗生素处方减少未增加上呼吸道感染及并发症发生率:一项大型人群队列研究
该研究基于瑞典斯德哥尔摩地区2014至2023年数据,分析门诊抗生素处方、上呼吸道感染及并发症趋势。结果显示,抗生素处方和上呼吸道感染持续减少,并发症发生率低,支持当前处方水平及抗菌药物管理项目的安全性。
要点
- 门诊抗生素处方减少与上呼吸道感染下降相关,未增加并发症风险。
- 扁桃体周围炎最常见(4.48-7.67例/万居民/年),其他并发症多低于1例/万居民/年。
- 脑膜炎和筛窦炎发病率下降,乳突炎略有年度增加。
核心结论
- 十年研究期间抗生素处方显著减少,但上呼吸道感染发作减少且并发症发生率低,支持当前处方水平及指南的安全性。
研究设计与样本
- 基于人群的队列研究,提取斯德哥尔摩地区数据仓库2014至2023年数据,覆盖全部居民的门诊、住院及药房抗生素发放记录。
主要发现
- 抗生素处方和上呼吸道感染持续减少,并发症发生率低。
- 扁桃体周围炎最常见,发病率为4.48-7.67例/万居民/年,其他并发症一般低于1例/万居民/年。
- 脑膜炎和筛窦炎发病率下降,乳突炎略有年度增加。
临床怎么用
- 研究结果支持当前上呼吸道感染临床实践指南及国家抗菌药物管理项目,门诊抗生素处方减少未导致并发症增加。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Inappropriate antibiotic use contributes to adverse events and resistance development. Implementation of antimicrobial stewardship (AMS) programmes has resulted in marked declines in outpatient antibiotic prescribing in several countries (e.g. Canada and Sweden). Upper respiratory tract infections (URTIs) are important targets for AMS interventions, because they are the most common indication for outpatient prescribing and are frequently overtreated. However, limited data exist to support that the reductions in antibiotic use are safe with respect to the incidence of primary infections and complications. This study aimed to safeguard that the observed declining trends in outpatient prescribing were not associated with clinically relevant increasing trends in URTIs, in a large Swedish cohort. METHODS: In this population-based cohort study, we extracted data recorded in the Stockholm Regional Data Warehouse (VAL) from 2014 to 2023. VAL encompasses primary care, outpatient secondary care, and inpatient care for all residents of the Stockholm health care region, and includes International Classification of Diseases, 10th Revision (ICD-10) diagnoses, consultation dates, hospital admissions, and pharmacy antibiotic dispensations. We first analysed trends in antibiotic prescriptions (per 1000 inhabitants/y), primary URTIs (diagnoses, episodes, and patients per 10 000 inhabitants/y) and complications. We then linked primary infection episodes to subsequent infectious complications, stratified by antibiotic treatment. RESULTS: Analyses revealed sustained reductions in antibiotic prescriptions and URTIs, and low complication rates. Peritonsillitis was most frequently recorded (4.48-7.67 cases per 10 000 inhabitants/y), whereas other complications generally occurred at rates below 1 case per 10 000 inhabitants/y. The incidence of meningitis and ethmoiditis declined, whereas mastoiditis showed a modest annual increase. CONCLUSIONS: Despite significant reductions in antibiotic prescribing over the 10-year study period, we found a decline in primary URTI episodes and low rates of complications. These findings support the safety of current prescribing levels and clinical practice guidelines for URTIs, as well as ongoing national AMS programmes.
引用
- Hedin K, Oscarson F, Cars T, et al. Reduced outpatient antibiotic prescribing is not associated with increased incidence of upper respiratory tract infections and complications: a large population-based cohort study. Clin Microbiol Infect. 2026. PMID: 42607833. doi:10.1016/j.cmi.2026.08.018
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。